Skip to main content

Value creation potential of intellectual capital in biotechnology – empirical evidence from Finland

Buy Article:

$51.00 plus tax (Refund Policy)

The objective of the study was to empirically verify impacts of intellectual capital (IC) to the anticipated future sales of small- and medium-sized companies within the biotechnology industry. The study creates and develops tools for the valuation of companies by relating the existing intangibles and the expected value creation of the companies in that industry displaying high growth prospects but long and insecure product development phases. Theoretically, IC is divided into the following three categories: human capital (HC), structural capital (SC), and relational capital (RC). In the empirical setting, survey data of small- and medium-sized Finnish biotechnology companies are used. In the econometric analyses, the interactions, or empirical co-variation, between the three categories of IC explain two-thirds of the variance in the anticipated future sales of the sample companies. Thus, it seems that a well-balanced combination of HC, SC, and RC implies value creation potential and high anticipated future sales.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Research Article

Affiliations: 1: ETLA, The Research Institute of the Finnish Economy, Lõnnrotin-katu 48, 00120, Helsinki, Finland , Email: raine.hermans@etla.fi 2: Asian Institute of Technology, School of Management, AIT PO Box 4, Km. 42 Phaholyothin Road, Klongluang, Phathumthani 12120, Thailand  ; ilkka.kauranen@hut.fi, Email: ilkka@ait.ac.th

Publication date: 2005-03-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more